|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07D 489/08 | (2006.01) |
| A61K 31/485 | (2006.01) | ||
| A61P 1/12 | (2006.01) | ||
| A61P 25/04 | (2006.01) |
| (11) | Number of the document | 1928882 |
| (13) | Kind of document | T |
| (96) | European patent application number | 06771162.2 |
| Date of filing the European patent application | 2006-05-25 | |
| (97) | Date of publication of the European application | 2008-06-11 |
| (45) | Date of publication and mention of the grant of the patent | 2013-09-04 |
| (46) | Date of publication of the claims translation | 2013-11-25 |
| (86) | Number | PCT/US2006/020232 |
| Date | 2006-05-25 |
| (87) | Number | WO 2006/127898 |
| Date | 2006-11-30 |
| (30) | Number | Date | Country code |
| 684570 P | 2005-05-25 | US |
| (72) |
WAGONER, Howard, US
SANGHVI, Suketu, P., US
BOYD, Thomas, A., US
VERBICKY, Christopher, US
ANDRUSKI, Stephen, US
|
| (73) |
PROGENICS PHARMACEUTICALS, INC.,
777 Old Saw Mill River Road, Tarrytown, NY 10591,
US
|
| (74) |
Liucija JANICKAITĖ,
Inpatra UAB, Šeškinės g. 59-53, LT-07162 Vilnius,
LT
|
| (54) | (S)-N-metilnaltreksonas, jo sintezės būdas ir jo panaudojimas farmacijai |
| (S)-N-METHYLNALTREXONE, PROCESS FOR ITS SYNTHESIS AND ITS PHARMACEUTICAL USE |
| Payment date | Validity (years) | Amount | |
| 2016-04-25 | 11 | 289.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2017-05-25 |